Home

vyrovnání Jahoda Fanatik event free survival overall leukemie sval George Hanbury Kolega

Blinatumomab Effective for Children with Relapsed Leukemia - NCI
Blinatumomab Effective for Children with Relapsed Leukemia - NCI

Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory  or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML  Registry Study
Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

The Expression Pattern of the Pre-B Cell Receptor Components Correlates  with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia |  PLOS ONE
The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia | PLOS ONE

Treatment outcomes of pediatric acute myeloid leukemia: a retrospective  analysis from 1996 to 2019 in Taiwan | Scientific Reports
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan | Scientific Reports

Interpretation of clinical endpoints in trials of acute myeloid leukemia -  ScienceDirect
Interpretation of clinical endpoints in trials of acute myeloid leukemia - ScienceDirect

Kaplan-Meier overall survival and event free survival curves of acute... |  Download Scientific Diagram
Kaplan-Meier overall survival and event free survival curves of acute... | Download Scientific Diagram

Cancers | Free Full-Text | Outcome of Relapsed or Refractory FLT3-Mutated  Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase  Inhibitors: A Toulouse–Bordeaux DATAML Registry Study
Cancers | Free Full-Text | Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study

Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic  Leukemia: A Possible Association between Survival Rate and ITPA  Polymorphism | PLOS ONE
Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism | PLOS ONE

First Randomized Trial to Show Benefit of Tyrosine Kinase Inhibitor in  Newly Diagnosed Acute Myeloid Leukemia - The ASCO Post
First Randomized Trial to Show Benefit of Tyrosine Kinase Inhibitor in Newly Diagnosed Acute Myeloid Leukemia - The ASCO Post

Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in  Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's  Oncology Group Trial AAML0531 | Journal of Clinical Oncology
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology

Kaplan–Meier Estimates of Event-free and Overall Survival among... |  Download Scientific Diagram
Kaplan–Meier Estimates of Event-free and Overall Survival among... | Download Scientific Diagram

SciELO - Brasil - Acute lymphoblastic leukemia in children and adolescents:  prognostic factors and analysis of survival Acute lymphoblastic leukemia in  children and adolescents: prognostic factors and analysis of survival
SciELO - Brasil - Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival

Acute Lymphoblastic Leukemia | NEJM
Acute Lymphoblastic Leukemia | NEJM

Overall survival and event-free survival according to primary... | Download  Scientific Diagram
Overall survival and event-free survival according to primary... | Download Scientific Diagram

Ivosidenib + azacitidine ups event-free survival in IDH1-mutated acute  myeloid leukemia
Ivosidenib + azacitidine ups event-free survival in IDH1-mutated acute myeloid leukemia

Outcomes after late bone marrow and very early central nervous system  relapse of childhood B-acute lymphoblastic leukemia: a report from the  Children's Oncology Group phase III study AALL0433 | Haematologica
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433 | Haematologica

Cureus | Absolute Lymphocyte Count at Day 28 Independently Predicts Event- Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphocytic  Leukemia
Cureus | Absolute Lymphocyte Count at Day 28 Independently Predicts Event- Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphocytic Leukemia

Kaplan-Meier survival curves of event-free survival (EFS) and overall... |  Download Scientific Diagram
Kaplan-Meier survival curves of event-free survival (EFS) and overall... | Download Scientific Diagram

A) Overall survival, (B) relapse-free survival, and (C) event-free... |  Download Scientific Diagram
A) Overall survival, (B) relapse-free survival, and (C) event-free... | Download Scientific Diagram

Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients  Treated With Hypomethylating Agents With or Without Venetoclax: A  Propensity Score-Adjusted Cohort Study
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study

Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St.  Jude Children's Research Hospital | NEJM
Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital | NEJM

Event free survival of 71 children with acute lymphoblastic leukemia... |  Download Scientific Diagram
Event free survival of 71 children with acute lymphoblastic leukemia... | Download Scientific Diagram

Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
Prognostic factors and treatment of pediatric acute lymphoblastic leukemia

Kaplan-Meier overall survival (OS) and event-free survival (EFS)... |  Download Scientific Diagram
Kaplan-Meier overall survival (OS) and event-free survival (EFS)... | Download Scientific Diagram

Figure 3 from Combination of hyper-CVAD with ponatinib as first-line  therapy for patients with Philadelphia chromosome-positive acute  lymphoblastic leukaemia: a single-centre, phase 2 study. | Semantic Scholar
Figure 3 from Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study. | Semantic Scholar